Effects of Varenicline and Cognitive Bias Modification on Neural Response to Smoking-Related Cues
- The School of Experimental Psychology is running a research project to test whether a smoking cessation drug (varenicline) and cognitive bias training modify brain responses to smoking-related cues in daily cigarette smokers.
- Participants will be asked to attend two sessions (one week apart) and will be randomised to receive either varenicline or placebo for seven days. On the second session participants would complete cognitive bias training and a cue-exposure test in an MRI scanner. Varenicline is a licensed smoking cessation drug with few side effects. You will be reimbursed for your time and expenses.
Find out more and sign up to participate
Please read the information sheet for more information.
For further information please contact Angela Attwood at Angela.Attwood@bristol.ac.uk